Keyword: Cinven


Cinven to Buy MBCC Admixture Assets from Sika

24.03.2023 -

Private equity investor Cinven is acquiring MBCC Group’s admixture business from Swiss construction chemicals major Sika on the rebound. Earlier, the British Competition...

Chemistry & Life Sciences

M&A Activity in the Chemical Distribution Industry

06.05.2022 -

Mergers & acquisitions activity in the chemical distribution industry was high in 2021, but current macro-economic conditions may have a dampening effect on the number of...


Cinven Purported Buyer of Bayer’s ESP Unit

10.03.2022 -

Private equity investor Cinven is poised to acquire Bayer’s Environmental Science Professional (ESP) unit, Bloomberg has reported. The news agency’s sources said the...


Lonza Specialty Ingredients to be sold to Bain Capital and Cinven

09.02.2021 -

Lonza has signed a definitive agreement to divest its Specialty Ingredients business to Bain Capital and Cinven for an enterprise value of CHF 4.2 billion.


Bayer Buoyed by Health and Agriculture in Q3

31.10.2014 - Buoyed by a strong performance in its Healthcare and CropScience businesses in the third quarter, Bayer has raised its forecast for full year 2014. CEO Marijn Dekkers said he...


Private Equity Bidders Circling Around BMS

24.10.2014 - Private equity companies Advent, Carlyle, Cinven, CVC and KKR are reported to be interested in teaming up with each other or sovereign wealth funds to bid for Bayer MaterialScience...


Cinven Could Acquire Medpace for $900 Million

24.02.2014 - Private equity firm Cinven, based in London, has agreed to acquire U.S. pharmaceutical contract research organization Medpace from buyout firm CCMP Capital Advisors for a little...


Cinven Buys Second Drug Business Amdipharm

15.10.2012 - Private equity group Cinven is buying family-owned niche pharmaceuticals business Amdipharm for 367 million pounds ($590 million), it said on Monday, as part of a plan to create a...